The global laboratory information systems market was is valued at $1.8bn in 2017 and is expected to grow at a CAGR of 8.3% from 2018 to 2028. In 2017, the software segment held 71% of the global laboratory information systems market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Laboratory Information Systems Market outlook from 2018-2028
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by delivery: • Web-based • On-Premise based • Cloud-based
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by application: • Clinical • Drug Discovery • Industrial
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by component: • Software • Hardware • Services
• This report provides individual revenue forecasts from 2018-2028 for these regional and national markets: • North America: US, Canada, Mexico • Europe: UK, Germany, France, Rest of Europe • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific • Rest of the World (RoW)
• Our study discusses the selected leading companies that are the major players in the laboratory information systems market: • Abbott Laboratories • Cerner Corporation • Eclipsys Corporation • LabVantage Solutions, Inc. • LabWare, Inc. • McKesson Corporation • Medical Information Technology, Inc. • Thermo Fisher Scientific
• This report provides a Porter’s Five Forces Analysis of the global laboratory information systems market.
Visiongain’s study is intended for anyone requiring commercial analyses for the biologics market. You find data, trends and predictions.
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
In the pharmaceutical industry, cell culture is progressively becoming a noticeable part of vaccine production. Previously, vaccines were manufactured by growing and harvesting viruses in chicken eggs, which was a time-consuming process. In this concern, cell-based vaccine production has developed as a far more efficient method due to its shortened lead-time and the capability to produce vaccines in larger quantities as per demand.
Meningococcal diseases is caused by a type of bacteria, it can lead to an infection of the bloodstream or meningitis, or both, and can be life taking if not quickly treated. The meningococcal conjugate vaccines are very affective at protecting against four strains of the bacteria while the MenB vaccine protects against a fifth strain.
Supervisory obligations in the healthcare industry to sustain compliance with good manufacturing practices, growing number of inspection frontiers in production lines, growing number of product evokes, rising dispersion of automated inspection systems in the pharmaceutical & biotechnology industries, and technological advancement in inspection systems are the major aspects driving the growth of this market.
Global Hydrophobic Interaction Chromatography (HIC) is one of the most extensively used methods for splitting and cleansing proteins in their native state. HIC also proves to be quite useful in isolating protein complexes and in studying protein folding and unfolding.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
